(7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
| 中文名称 | (7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione |
|---|---|
| 中文同义词 | 化合物 T32534;化合物 LADIRUBICIN |
| 英文名称 | (7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione |
| 英文同义词 | (7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;Ladirubicin;5,12-Naphthacenedione, 9-acetyl-7-[[3-(1-aziridinyl)-2,3,6-trideoxy-4-O-(methylsulfonyl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S,9S)- |
| CAS号 | 171047-47-5 |
| 分子式 | C29H31NO11S |
| 分子量 | 601.62 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 171047-47-5.mol |
| 结构式 | ![(7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione 结构式](CAS/GIF/171047-47-5.gif) |
(7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione 性质
| 沸点 | 800.3±65.0 °C(Predicted) |
|---|---|
| 密度 | 1.59±0.1 g/cm3(Predicted) |
| 酸度系数(pKa) | 7.79±0.60(Predicted) |
(7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione 用途与合成方法
Ladirubicin (PNU-159548) 是 Daunorubicin (HY-13062A) 的衍生物。Ladirubicin 具有 DNA 插入和 DNA 烷基化特性，可抑制 DNA 复制和转录，导致 DNA 损伤，从而发挥抗肿瘤活性。Ladirubicin 具有高亲脂性，因此具有穿透血脑屏障 (BBB) 的潜力。Ladirubicin 通过抑制骨髓活性而表现出毒性。